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Abstract 
Persons with cognitive impairment(s) are overrepresented in the criminal justice system 
(CJS) yet many instances of cognitive impairment go undiagnosed. As this article 
outlines, it would be both desirable and feasible to use automated alerts to flag accused 
persons who may require assistance in interacting with the CJS either due to a 
confirmed or likely diagnosis of a cognitive impairment or other relevant condition. A 
proposed method to develop this alert system is outlined, combining Natural Language 
Processing (NLP) applied to Electronic Health Records (EHRs) with data linkage (DL) 
of health and CJS data. Although there are technical barriers, this article focuses on the 
ethical and legal barriers of this proposed approach. It is concluded that the overall 
benefits of the proposed alert system would likely outweigh potential adverse 
outcomes. It is argued that a waiver of consent would be appropriate and that legal 
barriers, in terms of privacy legislation at both Federal and State levels, which apply 
varying requirements for the disclosure of personal information, may be overcome in 
part through de-identification strategies. The examples provided in this paper of 
criminological data linkage projects support the feasibility of the method proposed.  
 
Word count: 7909 
 
Key words: Criminal justice system, cognitive impairment, early detection, natural 
language processing, data linkage, electronic health records, ethics, privacy. 
 
 
	 
2	
Introduction 
 
It is widely recognised that individuals with cognitive impairments, including 
those with mental disorders, acquired brain injuries, fetal alcohol spectrum disorder, 
dementia, and a range of developmental intellectual disabilities, are overrepresented in 
the criminal justice system (CJS). Notably, it may be that a person has an unidentified 
cognitive impairment upon entry into the CJS or that they acquire such an impairment 
during incarceration (due to for instance traumatic brain injury, alcoholism/substance 
abuse, or dementia). However, many instances of these cognitive impairments are 
undiagnosed. It is imperative that individuals with cognitive impairments who come 
into contact with the CJS are identified as early as possible as having an impairment 
that may, if recognised and appropriately accommodated, improve their opportunities 
for equal access to justice and participation. Cognitive impairment covers a range of 
neuropsychological deficits that are associated with disabilities (restricted ability to 
perform activities) and underlying conditions and diseases (see for instance Mental 
Health Commission of NSW 2017; Stewart, Wilton & Sapers 2016). These deficits and 
disabilities may limit a person’s opportunities for equal access to and participation in 
justice processes (e.g. see White, Meares & Batchelor 2014). The focus of this paper is 
on the over-representation of people with cognitive impairments in the CJS and the 
ethical and legal feasibility of a proposed method to enhance early detection of such 
individuals. 
Improved identification of cognitive impairment and the corresponding 
provision of appropriate services in the CJS is a human rights issue (Human Rights 
Watch 2018). Articles 12 and 13 of the United Nations Convention on the Rights of 
Persons with Disabilities highlight that, in order to respect the rights to equal 
recognition before the law and access to justice, persons with disabilities must, 
wherever possible, be given every support and opportunity to participate in the CJS. 
This includes the opportunity to exercise their legal capacity and enter a plea, as well 
as their ongoing participation in the trial process and other proceedings throughout their 
time in the CJS. In order to achieve this, there must be appropriate support provided 
throughout this time. When such individuals are not identified or provided with 
appropriate supports in interactions with the CJS, there is a risk of breaching not only 
these rights but also their rights to due process, more generally (Australian Human 
Rights and Equal Opportunity Commission et al. 1989). This is at odds with ethical and 
legal principles of justice and fairness, which are central tenets of the CJS. 
 In addition to potential ethical and human rights breaches that may occur when 
individuals with cognitive impairments go unrecognised and unsupported, there are 
additional reasons for identifying such individuals as early as possible either before or 
when they first come into contact with the CJS. Australian researchers in particular (e.g. 
see Baldry, Briggs, Goldson & Russell 2018; Baldry, Clarence, Dowse, & Trollor 2013) 
have highlighted the complex connections between cognitive impairment, social 
disadvantage, complex needs, vulnerability to harms and involvement in the CJS. The 
presence of one of these adversities increases the likelihood of possessing another. 
Furthermore, those presenting with multiple adversities are likely to have earlier and 
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more frequent engagement with the criminal justice system. For these and other 
reasons, there have been numerous calls to improve and reform the fragmented 
response in Australia of the CJS to people with cognitive impairments (e.g. see Mental 
Health Commission of NSW 2017) and also to improve screening processes to identify 
individuals presenting with symptoms of cognitive impairment (see Human Rights 
Watch 2018).  
 Despite significant variation in statistics on prevalence rates of cognitive 
impairment within the CJS, owing in part to differing definitions of (Hellenbach, 
Karatzias & Brown 2017), and methodologies for identifying (Bronson, Maruschak & 
Berzofsky 2015) cognitive impairment, various scholarly sources acknowledge higher 
rates of cognitive impairment within prison populations, as compared to the general 
population. Some statistics have placed prevalence rates of cognitive impairment as 
high as 69%, and some have placed it as low as 4% (Hellenbach et al. 2017; Murphy, 
Gardner, & Freeman 2015). In Australia, it is estimated the prevalence of intellectual 
disabilities, just one type of cognitive impairment, is between 8 and 15% for offender 
cohorts compared to 3% in the general population. This figure is higher when offenders 
who have a borderline IQ are included in statistics (Shepherd, Ogloff, Shea, Pfeifer, & 
Paradies 2017).  
 Individuals with an average IQ who nonetheless exhibit characteristics of 
cognitive impairment are not captured in these statistics (Stewart et al. 2016). A key 
recommendation of a 2014 Australian Law Reform Commission (ALRC) report was 
that the Australian common law test of ‘unfitness to stand trial’ sets too high a threshold 
and is at odds with modern aims of the trial process. Arstein-Kerslake et al (2017, p. 
400) similarly stated that ‘there are persons with cognitive disabilities across the globe 
whose rights to legal capacity and a fair trial are being breached by unfitness to plead 
laws.’ The application of the test has also been too focussed on intellectual ability, 
without recognising that ‘cognitive impairment resulting from any neurological 
condition may not be detected on an IQ test, but may still significantly impact on a 
person’s ability to comprehend, communicate, and actively partake in legal 
proceedings’ (White, Meares & Batchelor 2014, p. 78). Even where an individual is 
declared unfit to stand trial, the result may be that the individual is indefinitely detained 
and may remain in custody for extended periods (ALRC 2014). Vulnerable and 
disadvantaged populations disproportionately experience such negative outcomes (e.g. 
see Shepherd et al. 2017). 
 As eluded to earlier, incarcerated persons may also develop or acquire a brain 
injury post trial or during incarceration. For instance, ageing in place within the prison 
may expose those incarcerated to conditions such as dementia (Williams et al. 2012). 
Furthermore, significant risk factors for dementia, such as low educational attainment, 
low physical activity, depression, stress, smoking and poorly managed vascular disease 
may either precede or accompany incarceration (Christodoulou 2012). Hence it is 
important to not only identify individuals with cognitive impairments in need of 
assistance at the pre-trial stage but also post-trial and during incarceration. 
 In this paper, we assess the potential utility of a method for early identification 
of individuals with cognitive impairment although the proposed method could be used 
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at any point in the CJS to aid identification. Early detection of cognitive impairment is 
essential to enhancing positive outcomes such as rehabilitation, crime prevention, and 
fair and just treatment, as well as preventing negative outcomes including reoffending 
and exacerbating pre-existing social disadvantage. An appealing practical solution to 
enhancing early detection is for criminal justice agencies to employ routine screening 
for cognitive impairment (Ogloff 2015). However, it is unclear at what point such 
screening should be undertaken and by whom. Ideally screening would occur at the 
earliest point of contact with the CJS so that individuals with cognitive impairments 
may be diverted where possible to more appropriate and potentially therapeutic 
avenues.  
 This suggests that screening could or should be undertaken by the police, who 
are typically the gatekeepers to the CJS. But could police officers themselves undertake 
screening assessments or should skilled clinicians do this? Given the sheer numbers of 
accused persons entering the system and relative shortage of skilled clinicians, it would 
be unrealistic to have trained clinicians on hand in every police station to undertake a 
gold standard assessment of each suspect. It seems more realistic that police themselves 
could undertake this screening using a validated screening tool. However, such tools 
do not necessarily cover the full range of cognitive impairments and disabilities that 
may impede an individual’s ability to participate equally in and achieve equal access to 
justice. Furthermore, a screening tool may still require some degree of clinical 
interpretation and training. Even if police could undertake such screening, another 
pertinent consideration is when screening should be conducted - before a suspect is 
interviewed or before a suspect is brought into custody? These issues aside, requiring 
police to undertake such screening would pose an unrealistic strain on resources both 
in terms of the time required to undertake the screening and in terms of the training 
required of police officers. Hence, an approach to early detection is required that would 
not place undue demands on already strained resources in the CJS while identifying 
individuals likely to require further assessment and possible assistance, with a relatively 
high degree of accuracy. Here we propose and explore the feasibility of a research 
method, involving Natural Language Processing (NLP) applied to Electronic Health 
Records (EHRs) combined with data linkage of health and CJS data, to develop 
automated alerts to flag individuals with a diagnosed cognitive impairment or who 
otherwise possess symptoms indicative of a cognitive impairment. These automated 
alerts could be used at multiple points throughout the CJS.  
 There is increasing recognition of the potential power of secondary research 
uses of the data contained in EHRs to transform the quality of life for the population as 
a whole through advances in knowledge about diseases, illnesses and impairments and 
how to more effectively treat or even prevent them. However, owing in part to the 
Value, Velocity, Volume, Veracity and Variety (the five Vs) of big data as well as 
privacy constraints (Watters et al. 2009), sophisticated methods of data extraction and 
analysis are required. We propose here the potential of a data mining method, NLP, to 
extract and analyse EHR data. In the context of enhancing early detection of cognitive 
impairment, NLP could be applied to text-based notes of clinicians contained in EHRs, 
extracting information identified as indicating a strong likelihood of cognitive 
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impairment. Information extracted from these records could form the input for 
classifiers and other algorithms to identify and predict patient characteristics using 
Machine Learning (ML). Cases identified as red flags in such EHRs could, in turn, be 
linked with CJS data so that CJS officials, at multiple points throughout the system, are 
notified early in any interactions with persons suspected of cognitive impairment. 
Although there are a number of technical difficulties that would need to be 
surmounted1, the purpose of this review is to assess the ethical and legal feasibility of 
our proposed research method.  
 
Electronic health records and their secondary uses 
 
EHRs are ‘health records of patients, which are securely stored in electronic 
form and shared between health-care providers’ (Spiranovic, Matthews, Scanlan, & 
Kirkby 2016, p. 14). This definition includes ‘electronic medical records, computerised 
patient records, computerised medical records, personal health records, and clinical 
data repositories’ (Spiranovic et al. 2016, p. 14). A more detailed definition has been 
outlined in Häyrinen, Saranto, and Nykänen (2008). 
 Primary uses of the clinical data within EHRs are uses that are directed at the 
care of the individual patient. Secondary uses go beyond the individual patient, and 
have been defined as ‘non-direct use of personal health information including but not 
limited to analysis, research, quality/safety measurement, public health, payment, 
provider certification or accreditation, and marketing and other business including 
strictly commercial activities’ (Meystre, Lovis, Bürkle, Tognola, Budrionis, & 
Lehmann 2017, p. 38). Access to clinical data for secondary uses is advantageous for 
many reasons, including the potential to promote higher quality healthcare, improved 
health management, reducing costs, and broader population health management and 
research (Meystre et al. 2017). 
 Secondary use of clinical data has been facilitated by a range of sophisticated 
data processing methods including data mining technologies such as NLP (see Liao, 
Cai, Savova, et al. 2015). Prior to the availability of data mining, extracting data from 
clinical notes required someone to manually read and extract data from hard-copy 
versions and only then could data be manually entered into a system to identify patterns 
(Meystre et al. 2017). NLP has been transformative (Liao et al. 2015). NLP has 
successfully been used, among other things, to detect warning signs of heart failure, to 
screen and predict adverse responses to certain drugs, and for genetic research (see 
Spiranovic et al. 2016). Furthermore, the CRIS-CODE project more recently provides 
some guidance for expanding NLP into mental illness. This project aimed to use NLP 
‘to offer comprehensive profiling from the mental health electronic record of symptoms 
and of interventions, outcomes and other relevant contextual factors currently only 
available from text fields’ (Jackson, Patel, Jayatilleke, Kolliakou, Ball, Gorrell, et al. 																																																								
1 In addition, NLP combined with ML would never be 100% accurate. Misclassification may result in 
incorrect decisions including (a) incorrectly identifying an individual as having an impairment, or (b) 
missing an impairment that is actually present. Hence, research in this area should seek to identify rates 
of false positives and false negatives.  
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2017, p. e012012). The results of the project demonstrated the potential for using NLP 
to extract symptoms of severe mental illness from patient discharge summaries, and 
identify common symptomology (Jackson et al. 2017). 
 In reviewing the applications of NLP, it seems plausible and feasible to apply 
NLP paired with Machine Learning (ML) techniques2 to clinicians’ notes contained in 
EHRs to enhance the detection of cognitive impairments. Both clinician-informed and 
statistically derived algorithms could be used to devise a list of terms associated with 
the various impairments that are included under the umbrella term cognitive 
impairment. EHR cases identified as likely to have a cognitive impairment and other 
cases in the EHR could then be compared on the actual known diagnosis3 as entered in 
the EHR to establish the validity of such an approach.   
 
Use of data linkage methods for criminological research 
Although it is at least plausible, in terms of our proposed research method, to 
apply NLP to EHRs to enhance early detection of cognitive impairment, what of the 
potential for enhancing early detection in the CJS? Although enhancing early detection 
of cognitive impairment in healthcare settings is an important outcome in itself, this 
information will not aid in identifying persons with cognitive impairment in the CJS if 
it is not accessed by CJS agencies. Linking EHR data with CJS databases would allow 
a red flag to be raised for those individuals who are likely to or have a confirmed 
diagnosis of cognitive impairment, at the point that a suspect’s or defendant’s details 
are entered. Such linkage of existing datasets represents a novel and potentially time- 
and cost-effective means of addressing an urgent problem facing the CJS.   
DL is essentially ‘the bringing together from two or more different sources, data 
that relate to the same individual, family, place or event’ (Holman, Bass, Rosman et al. 
2008, p. 767).’ There are already numerous data linkage initiatives across Australia, 
particularly in the health sector. One noteworthy example is the Personal Health 
Research Network (PHRN) which aims to provide researchers access to de-identified 
data to assist in population-level research (Boyd, et al. 2012). However, Ferrante (2009, 
p. 380) has argued that ‘compared with developments in the health sector, DL-based 
research in the Australian criminal justice sector is in almost embryonic form’. A 
decade ago now, Ferrante identified a few very promising Australian examples of DL 
in the CJS context. More recently, Baldry, Dowse and Clarence (2012) linked NSW 
data from human services and criminal justice agencies for 2,731 people in prison who 
were known to have a cognitive impairment in order to better understand offending 
patterns. The study indicated that ‘those with complex cognitive disability (ie 
comorbidity/dual diagnosis)’ were more likely to have earlier and more frequent 
contact with the CJS, to be homeless and to have limited education (Baldry et al. 2012, 
p. 14). Another example of criminological DL research is the Queensland Linkage 																																																								
2 On a technical note, NLP extracts the data, but does not provide detection or predictive ability. 
Machine Learning (ML) provides the latter.  3	The	authors	propose	to	use	a	forensic	patient	database	in	this	initial	validation	work	so	that	data	on	known	diagnoses	is	reliable.		
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Project, which has collected longitudinal administrative data on three separate cohorts 
who have had contact with child protection systems as well as the youth and adult CJSs 
(Stewart et al. 2015). These examples demonstrate the possibility and potential benefits 
of conducting research using DL and applying it to CJS issues. 
 While these pioneering studies show the feasibility of using DL in 
criminological research, legal barriers may limit widespread use. State and federal 
legislation limits the use of personal information, including clinical notes from EHRs, 
which has implications for the use of information for research generally, and 
particularly research involving the CJS. This is because the Privacy Act 1988 (Cth) ss 
95-95A and some state/territory privacy acts limit research exemptions to ‘medical and 
health research’, which does not include most CJS research. The issue of privacy will 
be explored in greater depth in the following section.  
 
Ethical and legal issues 
 
Secondary use of personal health data 
 
Privacy concerns have dominated public debate about the use of EHRs and are 
a key challenge for the expansion of secondary uses (Caine & Hanania 2013). Under 
Commonwealth and state/territory privacy legislation, personal information, including 
electronic health information, can only be used for the purpose for which it was 
collected. Exceptions apply where a person has given consent or for specified other 
activities deemed to be in the public interest. In most jurisdictions, this includes the 
exceptions for health and medical research.  
 
Relevant Australian privacy laws and research guidelines  
 
The data relevant for early detection of cognitive impairments will 
predominantly comprise personal health records, potentially governed by multiple 
privacy regimes. The Privacy Act 1988 (Cth) applies to records from private healthcare 
providers, including many general practitioners, as well as any Commonwealth-held 
data, such as Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme 
(PBS) data. State/territory privacy laws will apply to health records held by public 
hospitals. Some state/territory laws (e.g., NSW, Vic) also apply to health records of 
private providers, leading to multiple layers of regulation. 
 Integrating early detection of cognitive impairments with the CJS adds further 
complexity. CJS data may be covered by Commonwealth, state/territory privacy laws. 
Table 1 below provides a summary of the relevant federal, state/territory privacy 
legislation in Australia, specifically as it relates to the use or disclosure of health and 
non-health related data for research and the role of the Human Research Ethics 
Committee (HREC). The National Statement on Ethical Conduct in Human Research 
(National Statement) is the primary set of guidelines for human research in Australia 
(National Health and Medical Research Council, the Australian Research Council and 
the Australian Vice-Chancellors’ Committee 2015). The National Statement generally 
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requires research participants (including persons participating by virtue of use of their 
personal information) to provide explicit, voluntary, and informed consent. However, 
in some circumstances these consent requirements are waived.  For a waiver of consent 
to be approved, the Committee must be satisfied, among other things, that the benefits 
from the research justify any associated risks of harm, obtaining consent is 
impracticable, and that there is no likely reason for thinking that participants would not 
have consented if they had been asked. These requirements apply both to health and 
non-health related data.  
 
Table 1. Summary of privacy legislation on disclosure of health and non-health 
related data for research 
 
Jurisdiction Use or Disclosure of Health Data Use or Disclosure of Non-Health Data 
Cth The use or disclosure of health 
information is necessary for research 
relevant to public health or public 
safety and it is impracticable to 
obtain consent. Must also comply 
with guidelines issued by the 
NHMRC, which include a 
requirement for HREC approval 
(Privacy Act 1988 s 16B). 
No clear research exception for non-
health information in the Privacy Act 
1988. 
NSW The use of the information is 
reasonably necessary for research in 
the public interest, and either it is 
impracticable to obtain consent or 
reasonable steps are taken to 
deidentify the information. It must 
also comply with guidelines issued 
by the Privacy Commissioner 
(Health Records and Information 
Privacy Act 2002 sch 1, ss 10-11). 
The use or disclosure is necessary for 
research in the public interest and either 
it is impracticable to obtain consent or 
reasonable steps are taken to deidentify 
the information. It must also comply 
with guidelines issued by the Privacy 
Commissioner (Privacy and Personal 
Information Protection Act 1998, s 
27B). 
Vic The use or disclosure is necessary for 
research in the public interest, it is 
impracticable for the organisation to 
seek consent and the information is 
in a deidentified form (Health 
Records Act 2001 sch 1, s 2). 
 
The use or disclosure is necessary for 
research in the public interest and it is 
impracticable for the organisation to 
seek consent (Privacy and Data 
Protection Act 2014 sch 1) 
	 
9	
Qld The use or disclosure is necessary for 
research related to public health or 
safety, it is impracticable to obtain 
consent, is conducted in accordance 
with guidelines approved by the 
chief executive, and, for disclosure, 
that agency reasonably believes that 
the information will not be disclosed 
further (Information Privacy Act 
2009 sch 4, s 2(c)). 
The use or disclosure is necessary for 
research in the public interest, the 
information is in a deidentified form, 
and seeking consent is impracticable 
(Information Privacy Act 2009 sch 3, s 
10(f)).  
 
 
 
 
WA No legislative privacy regime No legislative privacy regime 
SA No specific state legislative privacy 
regime. There does not appear to be 
a research exception for health 
related data in the Government of 
South Australia Administrative 
Instruction (2016). 
No specific state legislative privacy 
regime. There does not appear to be a 
research exception for non-health 
related data in the Government of South 
Administrative Instruction (2016). 
TAS In addition to the use and disclosure 
exception relevant to all personal 
information, health information can 
be collected for research relevant to 
public health and public safety if it 
is in a deidentified form, it is 
impracticable to obtain consent, and 
the information is collected as 
required by law by competent 
professionals (Personal Information 
Protection Act 2004 sch 1, s 10(4)). 
The use or disclosure is necessary for 
research or statistics in the public 
interest and is not in a form that 
identifies any particular individual, and 
the agency reasonably believes that the 
recipient will not disclose the 
information. (Personal Information 
Protection Act 2004 sch 1, s 2(c)). 
ACT The use or disclosure is necessary for 
research in the public interest, it is 
impracticable to obtain consent, and 
the information is deidentified 
(Health Records (Privacy and 
Access) Act 1997, sch 1, s 10(3)). 
No specific research exceptions in the 
Information Privacy Act 2014. 
NT If use or disclosure is in the public 
interest, no individual will be 
identified, it is impracticable to 
obtain consent, and it is reasonably 
believed that the recipient will not 
disclose the information. Health 
information must also comply with 
any guidelines issued by the 
If use or disclosure is in the public 
interest and is in a deidentified form, it 
is impracticable to obtain consent, and 
it is reasonably believed that the 
recipient will not disclose the 
information (Information Act 2002 sch 
2, s 2.1(ca)). 
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Commissioner (Information Act 
2002 sch 2, s 2.1(ca); s 86(1)(a)(iv)).  
 
The requirements for release have broad similarities. Notably, in all 
jurisdictions with a specific legislative privacy regime, there are exceptions to use or 
disclosure of health data if the research is in the public interest, it is impracticable to 
obtain consent and/or data can be released in de-identified form.  The lack of clear 
research exceptions for non-health data (and, in some jurisdictions, for any personal 
information) can prevent DL initiatives, including those that link health and non-health 
data such as the project seeking to detect cognitive impairments in the CJS.  
 The prioritisation of health and medical data in a number of Australian 
jurisdictions is out of step with international comparators. Under s 33(1) of the UK 
Data Protection Act 1998, ‘research purposes’ are defined as statistical and historical 
purposes, without recourse to health or medical parameters. The Act exempts data 
processed for research purposes from the proscription on use and disclosure if the data 
will not identify a specific individual, and the research activity is unlikely to cause 
damage or distress to persons to whom the information relates. 
 In Canada, the use and disclosure of personal information is regulated under s 
7(2)(c) of the Personal Information Protection and Electronic Documents Act 2000 SC 
2000. Under s 7(3)(f) of the Act, disclosure of personal information is permissible for 
research purposes, where the purpose cannot be achieved without such a disclosure; it 
is impracticable to obtain the consent of persons to whom the information relates; and 
the organisation informs the Commissioner of the disclosure before it occurs. The NZ 
Privacy Act 1993 specifies an even more permissive regime excepting under Principle 
2(g), information used for research purposes if it is de-identified and will not be 
published in a form where the individual is identified. Again, this applies equally to 
health and non-health data. 
 There is no clear policy reason for differentiating between health and non-health 
data for research, particularly given the often-blurry line between these categories. In 
its pivotal 2008 report into privacy laws, the ALRC recommended that the Privacy Act 
be amended to extend research exceptions for health and medical data to cover human 
research more generally (2008). An emerging emphasis on ‘open data’ in Australia and 
elsewhere (see for instance https://researchdata.ands.org.au) may help to shift this 
paradigm further in favour of criminological research in the future.  Having said this, 
there are several factors that may justify a more cautious approach where 
criminological projects are concerned including the sensitive subject matter, the 
vulnerable and typically disadvantaged target group and the inherent power imbalance 
between corporate/state bodies and the individual (Israel 2004). 
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Addressing privacy concerns 
 
Deidentification methods for electronic health records 
 
In considering the relevance of privacy laws to the proposed method for 
enhancing detection of cognitive impairment in the CJS, it is pertinent to note that 
privacy laws only apply to ‘personal information’, which is generally limited to 
information about an identified or ‘reasonably identifiable’ individual (see for instance 
Privacy Act 1988 (Cth), s 6). To the extent that research can proceed with sufficiently 
de-identified information, researchers will be able to circumvent most legal and ethical 
privacy concerns. However, by definition, DL requires information about the same 
individual using patient identifiers, such as a date of birth or postcode, which carries an 
inherent risk of re-identification. Generally, the DL process is as follows: an important 
life-event occurs; data is collected and stored; technology is used to link records 
belonging to the same person from different events; numbers or ‘linkage keys’ are 
created to identify the records as belonging to the same person; and finally, linkage 
keys are stored (Department of Health WA 2017). These encrypted linkage keys can 
sometimes be extracted and used in research (Department of Health WA 2017).  
 Strategies to circumvent the legal and ethical concerns are usually 
straightforward including the use of DL keys. Research ethics committees also 
commonly issue waivers of consent for DL research projects when the first ‘use’ of 
data is deidentification, provided adequate security protocols are in place (El Emam 
2011). In some instances, research carries minimal risk but where the information is 
sensitive there is more potential for harm or discrimination as a result of reidentification 
or misuse of information (Porsdam Mann, Savulescu & Sahakian 2016). The risks are 
therefore likely heightened in our proposed method for enhancing detection of 
cognitive impairment in the CJS as this involves not only data linkage of sensitive 
health and CJS data but also the analysis of clinician entered free text in EHRs.  
 A particularly challenging problem with our proposed method is the potential 
for identifying information (e.g. names of people/locations, diagnosis, descriptions of 
criminal behaviours) to be retained in EHR free text. Free text—the essential element 
of NLP—is harder to strip of identifying information, where more specific and limited 
data items are being collected. Algorithms have been developed to de-identify clinical 
notes, which report quite high levels of accuracy (e.g. see Fernandes et al. 2013). 
However, some potential for privacy breaches remain, especially in instances of data 
entry errors or incorrectly spelled information that systems may not recognise 
(Fernandes et al. 2013).  
Information extraction algorithms also encounter some errors due to lexical 
ambiguity and other constraints, which appear hard to completely address, due to 
overlap between personal identifiers and medical or other common use terms, such as 
names that also operate as physical attributes like ‘Green’ and ‘Brown’ (Morrison, Li, 
Lai & Hripcsak 2009). Rich text can also lead to re-identification even in the absence 
of traditional patient identifiers. One example of re-identification occurred using ‘de-
identified’ medical records that included the profession of the patient’s father and his 
	 
12	
region of work (El Emam 2011). Systems are likely to improve but will not provide a 
complete solution. This is especially true for small jurisdictions and for rare diseases 
because relational information can more easily result in probabilistic identification of a 
patient (El Emam 2011). In any case, there is increasing recognition that true de-
identification is less feasible in the age of big data/data linkage and that re-identification 
is always a risk (e.g. see Lipworth, Mason, Kerridge & Loannidis 2017).  
Despite these difficulties in achieving deidentified data, from a public good 
perspective (e.g., see Ballantyne & Schaefer 2018), the overall perceived benefits of 
the proposed method particularly in terms of addressing inequities in access to justice 
for vulnerable persons, notwithstanding risks, which may be mitigated, may justify a 
waiver of consent. 
 
Consent considerations 
 
There are some unique considerations around consent raised by our proposed 
research. In particular, the target population is a vulnerable population. Section 4 of the 
National Statement (NHMRC et al. 2015) outlines the unique ethical considerations for 
research involving persons with a cognitive impairment. One noteworthy challenge is 
the likelihood that some patients will not (or will no longer) have the ability to consent 
to sharing health information. Nonetheless, human rights and disability rights 
frameworks point towards the importance of principles such as inclusion and respect 
for autonomy which promote the involvement of persons with cognitive impairments 
in research provided there are adequate safeguards to reduce potential harms (e.g., see 
McDonald, Conroy, & Olick 2017; McDonald & Raymaker 2013).  
 Individual participant consent, where an allowable exception in privacy laws 
exists, is the gold standard for research with identifiable and/or sensitive information. 
However, obtaining consent is often not practicable for DL activities, given the 
typically large population size, potential delay between an EHR being generated and a 
researcher seeking access, and participation bias. Therefore, seeking specific 
participant consent for a given data linkage project often will not be possible/feasible 
particularly in retrospective research where data has already been collected. As 
mentioned in the preceding section, a waiver of consent may be warranted in such 
instances.  
 However, in prospective research where data is yet to be collected, 
implementation of electronic health systems affords an opportunity to incorporate 
‘privacy aware’ strategies in the initial architecture. ‘Broad consent’ models involve a 
single opportunity to give consent to all future research of a particular type, rather than 
on a case-by-case basis (Ploug & Holm 2015). Ideally, broad consent would be obtained 
at the inception of an EHR (Kosseim & Brady 2008). While this overcomes some issues 
with obtaining consent, a key problem with any broad consent model is that participants 
cannot truly provide informed consent in advance as participants would be unlikely to 
foresee all possible research uses of their data (Kosseim & Brady 2008).  
 A dynamic model, on the other hand, involves information about specific data 
relating to each new application being provided to participants online, along with an 
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option to withhold consent (Ploug & Holm 2015). It has been suggested that dynamic 
consent models facilitate the consent process as well as ongoing communication 
between researchers and participants (Williams et al. 2015). Despite these and other 
apparent benefits, dynamic models are in an early stage of development and evaluation 
as to their practicability.  
 Ploug and Holm (2015) suggest a middle path: a meta consent model, which 
combines broad and dynamic consent. The rationale ‘is simply to let individuals choose 
how they wish to provide consent for future secondary research of data collected in the 
past or of data that will be stored in the future’ (Ploug & Holm 2017, p. 2). Arguably, 
this could provide a flexible and practical solution, as well as appropriate respect for 
individual autonomy (Ploug & Holm 2017, p. 3).  
 For any of these strategies to be successful, they need to be addressed at the 
time of implementation. Once an EHR system is operational, re-consent processes will 
likely be considered unfeasible (Kosseim & Brady 2008). Whatever method is adopted, 
there is a need to ensure that any consent strategies incorporated into secondary uses of 
EHRs are meaningful. The mere notion of personal control cannot be taken as a panacea 
for privacy concerns or an imprimatur of ethical acceptability (Spriggs, Arnold, Pearce 
& Fry 2012). 
 
Summary and Discussion 
 
As this paper has outlined, the legal and human rights of persons with a 
cognitive impairment are breached when they do not receive the support they require 
to participate equally and effectively in CJS proceedings. There are a multitude of 
underlying neurological conditions that may give rise to a cognitive impairment which 
impedes on the ability of a person to communicate effectively and participate in CJS 
processes. To address the call for improved recognition and support of all such 
individuals in the CJS, screening at various points of the CJS is an intuitively appealing 
approach. However, as outlined in this paper, there are numerous reasons to suspect 
that widespread screening may not be feasible. Cost-effective and efficient alternatives 
to screening are desirable. For these and other reasons, an alternative method for 
enhancing detection of cognitive impairments in the CJS was proposed. The proposed 
method includes NLP combined with ML of EHRs to identify from clinician entries 
persons who have or are likely to have a cognitive impairment. Linking these health 
records with CJS data in turn would allow for red flags to be issued to CJS officers 
when the accused person’s details are entered into a CJS database.   
 Although there are technical barriers to the proposed method, this article 
focused on the ethical and legal barriers of the proposed method. A review of federal 
and state/territory privacy legislation highlighted that limitations on disclosure of 
personal information and the absence of exceptions for research in some jurisdictions 
and for non-health research in others may impede the widespread implementation of 
the proposed approach. Nonetheless, it was suggested that data linkage keys and 
deidentification strategies as employed in large scale successful DL initiatives may 
overcome, in part, this legislative obstacle. It was also suggested that the broader nature 
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of exceptions to disclosure as employed in some other counties combined with moves 
towards open data more generally may, moving forwards, promote DL initiatives such 
as the one proposed here.  
 A further barrier identified was that of consent. Where exceptions to disclosure 
are permitted for non-health related research, a common requirement is that consent is 
granted for this disclosure. In terms of the proposed method to enhance detection of 
cognitive impairment, re-consent would be required for data linkage involving 
retrospectively collected data and prospective consent would be required for any new 
data collection and linkage. As outlined in this paper, there are complexities involved 
in obtaining informed consent from a person with a cognitive impairment. However, 
this should not preclude the right of such individuals to participate in research. In any 
case, a waiver of consent for the proposed research would likely be granted by an ethics 
committee primarily on the grounds that it would be impractical to obtain consent due 
to the large-scale and retrospective nature of the research and the proposed benefits 
would outweigh the risks (namely identification or reidentification.  Ideally though, 
prospective data linkage projects may be aided by a consent model inbuilt in EHRs and 
other health data repositories although it is unclear which model for consent (broad, 
dynamic or a blend of these two) may achieve the best balance between upholding 
individual patient rights and facilitating research advancements, which could likely lead 
to enhanced population health outcomes. 
 In conclusion, the proposed method for enhancing detection of cognitive 
impairment in the CJS offers considerable promise as a means to uphold the rights of 
accused persons with disabilities to receive the support they require in accessing and 
participating equally and effectively in CJS proceedings. As evidenced by a number of 
successful DL criminological projects in Australia, ethical and legal issues raised by 
the proposed research could be addressed successfully.  
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